Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine clinical response in major depressive disorder with two traditional Chinese medicine patterns
ChiCTR-OPC-15005947Phase 4Not yet recruiting
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of venlafaxine in major depressive disorder (MDD) (3 arms), sponsored by Tongde Hospital of Zhejiang Province. Primary endpoint: Hamilton Rating Scale for Depression. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-OPC-15005947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15005947.